Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Gazprom, Saturn Oil & Gas, Shell - Winners of a supply chain law

In recent weeks, the German media have frequently reported on a so-called supply chain law. The aim of such a law is to ensure that German companies respect human rights and protect the environment in the procurement of materials and products. The world should become a bette...

Gold reacting to global flash points

Gold’s safe haven status was tested this week, as Iran countered the assassination of its top military commander with missile strikes against two Iraqi bases housing US troops. On Tuesday night Tehran fired over a dozen missiles at the Al-Asad airbase and E...

3D printing is a manufacturing game-changer

Calling all carnivores: ever thought about getting a meat printer? Of hand-crafting delectable beef steaks at home from plant proteins, that have the same texture, appearance and flavor as real meat, only without the distasteful killing part? 3D-printed steaks and chicken ...

Allakos Shares Double on AK002 Phase 2 Results and Earnings

Allakos Inc. shares are soaring today as the company reported Q2/19 earnings and announced positive results from its phase 2 study for its AK002 inhibitor used in the treatment of eosinophil and mast cell related diseases. Clinical stage biotech company Allak...

Surface Oncology Shares Trade Up 40% on Phase1 Study Plans for SRF617 Combined with Merck's KEYTRUDA

Shares of Surface Oncology set a new 52-week high price after the company reported that it is partnering with Merck & Co. in an immuno-oncology study of SRF617, targeting CD39 in combination with KEYTRUDA® (pembrolizumab) in solid tumor patients. Clinical-...

China’s Actions to Jumpstart a New Industrial Sector in US & Canada

Byron King, Managing Editor The Fire Bell Is Ringing! Hi Byron, ...

Stronger. Faster. Cheaper. Welcome to the New EV Charging Station

The electric vehicle (EV) revolution is now in full gear, but there still remains a few obstacles to get more buyers into the market – namely EV range anxiety or the fear that their car's battery will die on them mid-trip. Now, there’s a single-source soluti...

Will People Accept Rampant Inflation? Hell, No!

The Weekly Missive, which usually arrives over the weekend (sometimes on Friday, sometimes on Sunday) was delayed this weekend for one reason: I had to change it. I started out last week with an idea that was leaning in the direction of full-on capitulation in the sen...

The growing weaponization of space

In his recent State of the Union address, President Trump gave a shout-out to space exploration, highlighting the newly-created Space Force branch of the US Military, and NASA’s Artemis program of crewed lunar exploration. Artemis aims to put astronauts on ...

Dissecting the Stock Bubble Debate: Flow Versus Value

"For every action, there is an equal and opposite reaction." —Sir Isaac Newton (Newton's Third Law) In nature, where everything moves freely absent human interference, her omnipotent forces are allowed to manifest themselves in manners that create a living ecosystem t...
1 2 3 4 5 6 7 8 9 10 ...